Methylphenidate or Dexmethylphenidate (Concerta, Ritalin and others)

Brand names:

  • Ritalin®, Methylin® (methylphenidate, immediate release)
    • Tablet: 5 mg, 10 mg, 20 mg
    • Chewable tablet: 2.5 mg, 5 mg, 10 mg
    • Liquid: 5 mg/5 mL and 10 mg/5 mL
  • Ritalin LA® (methylphenidate, extended release)
    • Capsule: 10 mg, 20 mg, 30 mg, 40 mg, 60 mg
  • Metadate ER®, Ritalin SR® (methylphenidate, extended release, wax matrix)
    • Tablet: 10 mg, 20 mg
  • Metadate CD® (methylphenidate, controlled delivery)
    • Capsule: 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
  • Methylin ER® (methylphenidate, extended release, methylcellulose base)
    • Tablet: 10 mg, 20 mg
  • Aptensio XR® (methylphenidate, extended release)
    • Capsule: 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
  • Concerta® (methylphenidate, extended release)
    • Caplet: 18 mg, 27 mg, 36 mg, 54 mg 
  • Daytrana® (methylphenidate patch)
    • Patch: 10 mg, 15 mg, 20 mg, 30 mg
  • Quillivant XR® (methylphenidate, extended-release oral suspension)
    • Liquid: 25 mg/5 mL
  • Quillichew ER® (methylphenidate HCL, extended release, chewable)
    • Chewable tablet: 20 mg, 30 mg, 40 mg
  • Focalin® (Dexmethylphenidate, immediate release)
    • Tablets: 2.5 mg, 5 mg, 10 mg
  • Focalin XR® (dexmethylphenidate, extended release)
    • Capsule: 5 mg , 10 mg, 15 mg, 20 mg, 25 mg, 30 mg, 35 mg
  • Jornay PM® (methylphenidate HCL, extended release)
    • Capsule: 20 mg, 40 mg, 60 mg, 80 mg, 100 mg
  • Cotempla XR-ODT® (methylphenidate, extended release)
    • Oral disintegrating tablet: 8.6 mg, 17.3 mg, 25.9 mg

Generic names: methylphenidate (METH il FEN i date) or dexmethylphenidate (DEX meth il FEN i date)

All FDA black box warnings are at the end of this fact sheet. Please review before taking this medication.

What are methylphenidate or dexmethylphenidate and what do they treat?

Methylphenidate or dexmethylphenidate are prescription medications that are used to treat children over 6 years old, adolescents, and adults with attention-deficit hyperactivity disorder (ADHD).

Symptoms of ADHD interfere with an individual’s ability to function at school or work or in social settings and include:

  • Inattention (e.g., making careless mistakes, losing things necessary for tasks)
  • Hyperactivity (e.g., inability to sit still)
  • Impulsivity (e.g., interrupting or intruding on others)

Hyperactivity is less common in adults. A person may have severe inattention without hyperactivity or impulsivity.

Methylphenidate or dexmethylphenidate are used in addition to non-medication treatments to manage ADHD symptoms.

What is the most important information I should know about methylphenidate or dexmethylphenidate?

Although some symptoms may improve within days of starting methylphenidate or dexmethylphenidate, it may take several weeks before you notice the full benefits of the medication.

Are there specific concerns about methylphenidate or dexmethylphenidate and pregnancy?

If you are planning on becoming pregnant, notify your healthcare provider so that he/she can best manage your medications. People living with ADHD who wish to become pregnant face important decisions, each with risks and benefits as they relate to how the illness, medications, and risks to the fetus may interact. This is a complex decision as untreated ADHD has risks to the fetus as well as the mother. Therefore, it is important to discuss this with your doctor and caregivers.

Regarding breast-feeding, caution is advised since methylphenidate does pass into breast milk and there is limited information available about the safety of dexmethylphenidate while breastfeeding.

What should I discuss with my healthcare provider before taking methylphenidate or dexmethylphenidate?

  • The most bothersome symptoms of your condition
  • If you have thoughts of suicide or harming yourself
  • If you experience side effects from your medications, discuss them with your provider. Some side effects may pass with time, but others may require an adjustment in the medication
  • Any other psychiatric or medical problems you have, including heart disease
  • All other medications you are currently taking (including over the counter products, herbal and nutritional supplements) and any medication allergies you have
  • Other non-medication treatment you are receiving, such as talk therapy or substance abuse treatment. Your provider can explain how these different treatments work with the medication.
  • If you are pregnant, plan to become pregnant, or are breast-feeding
  • If you drink alcohol or use drugs

How should I take methylphenidate or dexmethylphenidate?

Methylphenidate or dexmethylphenidate is usually taken one to three times per day with or without food.

While the dose usually varies, your healthcare provider will determine the dose that is right for you based upon your response.

  • Immediate release formulations should be given two or three times a day to provide symptom coverage throughout the day.
  • Extended release and long-acting medications that last for 8 to 12 hours should be taken once a day in the morning. The capsules with beads may be opened if a person has trouble swallowing, however, the beads should be swallowed whole without chewing. If the beads are chewed, too much medicine is absorbed at once and the effects will not last as long.
  • The tablet shell from the Concerta® tablet is not changed in the intestines and may appear in the stool intact. It should not be given to individuals with narrowing of the intestines or in those who have undergone stomach bypass surgery.
  • The methylphenidate patch should be applied to a clean, hair-free area in the morning before school and removed approximately 9 hours later for an approximate 12-hour duration of action.
  • When taking Quillivant XR® (methylphenidate extended release oral suspension), shake the bottle vigorously for at least 10 seconds to make sure the medication is mixed properly. Be sure to use the oral dose dispenser provided and to clean the dispenser after each use.
  • When taking Jornay PM®, doses should be administered in the evening.
  • When taking Cotempla XR-ODT® ensure hands are dry when removing from the blister packs by peeling back (not pushing through the foil) and administer immediately. Do not chew or crush tablet and allow it to dissolve on the tongue.

Use a calendar, pillbox, alarm clock, or cell phone alert to help you remember to take your medication. You may also ask a family member or a friend to remind you or check in with you to be sure you are taking your medication.

What happens if I miss a dose of methylphenidate or dexmethylphenidate?

If you miss a dose of methylphenidate or dexmethylphenidate, take it as soon as you remember, unless it is closer to the time of your next dose. Discuss this with your healthcare provider. Do not double your next dose or take more than what is prescribed.

Do not take a missed dose after 5:00 PM, as this may interfere with sleep.

What should I avoid while taking methylphenidate or dexmethylphenidate?

Avoid drinking alcohol or using illegal drugs while you are taking methylphenidate or dexmethylphenidate. The beneficial effects of the medication may be decreased and adverse effects may be increased.

What happens if I overdose with methylphenidate or dexmethylphenidate?

If an overdose occurs call your doctor or 911. You may need urgent medical care. You may also contact the poison control center at 1-800-222-1222.

Overdosing with methylphenidate or dexmethylphenidate may lead to nausea and vomiting, rapid heart beat, abnormal heart rhythms, paranoia, hallucinations and seizures.

What are possible side effects of methylphenidate or dexmethylphenidate?

Common side effects

  • Upset stomach, loss of appetite, insomnia, and mild anxiety

Rare side effects

Contact your healthcare provider if any of the following occur while taking methylphenidate:

  • Significant increases in blood pressure or heart rate, shortness of breath, fatigue
  • Severe anxiety, panic attacks, mania, hallucinations, paranoia or delusions
  • Severe muscle pain, weakness, signs of dehydration, or dark urine
  • Prolonged or painful erection
  • Changes of feeling or color in your fingers or toes

Serious side effects

Medications like methylphenidate or dexmethylphenidate should be avoided in individuals who have a heart defect (structural abnormalities), uncontrolled high blood pressure, or a disorder of the heart or blood vessels.

Both methylphenidate and dexmethylphenidate are rarely associated with clinically significant increases in blood pressure or heart rate. Blood pressure and heart rate should be monitored before starting medication, and then weekly while adjusting the dose and then every 1 to 3 months or when side effects like “racing heart,” shortness of breath or exercise fatigue becomes problematic.

Are there any risks for taking methylphenidate or dexmethylphenidate for long periods of time?

Methylphenidate or dexmethylphenidate is a Schedule II controlled substance, similar to other stimulant medications, such as amphetamine, mixed amphetamine salts, dextroamphetamine and lisdexamfetamine. There is a risk of physical and/or emotional dependence (addiction) when it is taken for long periods of time.

Although treatment with these medications can slow growth, many studies have shown that these changes are small, and children may catch-up with growth over time, therefore this should not be a concern for most children. Height, weight, and eating habits should be discussed before treatment starts and regularly during treatment. If you are concerned about a child's growth, discuss other possible treatments with your child's doctor.

What other medications may interact with methylphenidate or dexmethylphenidate?

Medications used to treat depression such as tricyclic antidepressants (TCA) and monoamine oxidase inhibitors can interact with these medications resulting in serious reactions, including high body temperature, high blood pressure, and seizures (convulsions). Tell your healthcare provider if you are beginning or have recently discontinued any of these medications.

Methylphenidate and dexmethylphenidate should not be taken with or within 2 weeks of monoamine oxidase inhibitor antidepressants (MAOIs), including phenelzine (Nardil®), Tranylcypromine (Parnate®), selegiline (Emsam®), and isocarboxazid (Marplan®) or the antibiotic linezolid (Zyvox®). Taking stimulants with or within 2 weeks of MAOIs can result in seizures, fever or dangerously high blood pressure that can lead to death.

The following medications may increase the levels and/or effects of methylphenidate or dexmethylphenidate:

  • Atomoxetine (Strattera®), caffeine, alcohol, phenylephrine, fluoxetine (Prozac®), bupropion (Wellbutrin®), venlafaxine (Effexor®), duloxetine (Cymbalta®), Modafinil (Provigil®), and armodafinil (Nuvigil®)

Methylphenidate or dexmethylphenidate may increase the levels and effects of: some seizure medications such as phenobarbital or phenytoin, warfarin, and tricyclic antidepressants such as desipramine or clomipramine.

Methylphenidate or dexmethylphenidate may decrease the levels and effects of: some blood pressure medications such as clonidine, guanfacine, guanethidine and guanadrel.

How long does it take for methylphenidate or dexmethylphenidate to work?

Although you may experience beneficial effects from methylphenidate or dexmethylphenidate within a few days of starting the medication, it often takes several weeks to get the full effect of the medication. Your healthcare provider may also need to adjust gradually the dose to find the dose that works best for you.

Summary of FDA Black Box Warnings


Medications like methylphenidate or dexmethylphenidate should be given cautiously to patients with a history of drug dependence or alcoholism. Chronic abusive use can lead to marked tolerance and psychological dependence. Psychotic episodes can occur, especially when injected. Careful supervision is required during withdrawal from abusive use, since severe depression may occur. Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow-up.


Provided by

(August 2019)

©2019 The College of Psychiatric and Neurologic Pharmacists (CPNP) and the National Alliance on Mental Illness (NAMI). CPNP and NAMI make this document available under the Creative Commons Attribution-No Derivatives 4.0 International License. Last Updated: January 2016.

This information is being provided as a community outreach effort of the College of Psychiatric and Neurologic Pharmacists. This information is for educational and informational purposes only and is not medical advice. This information contains a summary of important points and is not an exhaustive review of information about the medication. Always seek the advice of a physician or other qualified medical professional with any questions you may have regarding medications or medical conditions. Never delay seeking professional medical advice or disregard medical professional advice as a result of any information provided herein. The College of Psychiatric and Neurologic Pharmacists disclaims any and all liability alleged as a result of the information provided herein.